Articles

Poll

Podcasts

Slideshows

Videos

Gastroenterology

Gastroenterology condition center page is a comprehensive resource for clinical news and insights on digestive and GI conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for 

, IBS and IBD, Crohn's disease, and more.

Review the biggest gastroenterology news from the first half of 2026, including FDA updates, IBD advances, and key clinical trials.

First Half 2026 Recap: Gastroenterology

Catch up on Q2 GI headlines you may have missed, including an expanded FDA approval for linaclotide, a submission for risankizumab SC induction in Crohn’s, and more.

Q2 2026 Recap: Gastroenterology News & Updates

Catch up on phase 3 data for tulisokibart and obefazimod, expert perspective on linaclotide's expanded FDA approval, and more.

4 Gastroenterology Headlines You Missed in June 2026

Catch up on GI regulatory actions and top headlines from DDW in this May month in review.

6 Gastroenterology Headlines You Missed in May 2026

Study 108 interim data show 68% of UC patients remained in clinical remission at week 144 after de-escalating from 50 mg to 25 mg obefazimod daily.

Obefazimod Sustains Remission After Dose Reduction in UC Extension Trial

Chedid describes the future of personalizing IBD care based on patient characteristics. 

Persistent Symptoms, Equity Gaps, Pushing For Whole-Person IBD Care, With Victor Chedid, MD, MS

Catch up on new IBD drug trial data, regulatory actions, and updates in IBS in this April month in review.

5 Gastroenterology Headlines You Missed in April 2026

Despite a growing armamentarium of approved IBD therapies, outcomes remain suboptimal. Rubin explains how earlier treatment and smarter optimization can close the gap.

Closing the Gap Between IBD Therapies and Patient Outcomes, With David Rubin, MD

Laurent Peyrin-Biroulet, MD, PhD, breaks down FUZION data demonstrating meaningful fistula healing with guselkumab in Crohn’s disease patients with perianal disease.

Phase 3 FUZION Data Support Guselkumab in Perianal Fistulizing Crohn’s Disease

Routine depression and anxiety screening in IBD clinics was tied to significantly more referrals and sustained follow-up with psychogastroenterology services

Mental Health Screening in IBD Linked to Increased Psychogastroenterology Uptake

On the HCPLive inflammatory bowel disease page, resources on the topics of medical news and expert insight into IBD can be found. Content includes articles, interviews, videos, podcasts, and breaking news on IBD and more.

Inflammatory Bowel Disease